For more details, please follow the link below:
https://www.datitude.co.uk/post/datitude-new-client-partnership-with-skinbiotherapeuticsplc
CEO presentation at Shares investor event
Doug Quinn, CFO, updates on the Proposed Placing and Open Offer
Circular for Proposed Placing and Open Offer
Proposed Placing and Open Offer
SkinBioTherapeutics plc (AIM: SBTX or the “Company”) a life sciences company focused on skin health, is pleased to announce it has conditionally raised £4.0 million by way of a Placing to new and existing institutional investors.
Furthermore, to enable other Shareholders who are not able to participate in the Placing an opportunity to subscribe for new Ordinary Shares, the Company is proposing to raise up to an additional c.£0.5 million by way of an Open Offer made to Qualifying Shareholders.